California State Teachers Retirement System Sells 9,429 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

California State Teachers Retirement System reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 4.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 205,113 shares of the company's stock after selling 9,429 shares during the period. California State Teachers Retirement System owned approximately 0.17% of Henry Schein worth $14,194,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of HSIC. Wealth Enhancement Advisory Services LLC grew its stake in Henry Schein by 34.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 52,891 shares of the company's stock valued at $3,660,000 after acquiring an additional 13,431 shares in the last quarter. Siemens Fonds Invest GmbH lifted its holdings in shares of Henry Schein by 282.3% during the 4th quarter. Siemens Fonds Invest GmbH now owns 13,366 shares of the company's stock valued at $925,000 after buying an additional 9,870 shares during the last quarter. Menard Financial Group LLC acquired a new stake in shares of Henry Schein during the 4th quarter valued at about $92,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Henry Schein during the 4th quarter valued at about $5,743,000. Finally, Jefferies Financial Group Inc. lifted its holdings in shares of Henry Schein by 98.8% during the 4th quarter. Jefferies Financial Group Inc. now owns 83,100 shares of the company's stock valued at $5,751,000 after buying an additional 41,300 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded up $0.61 on Wednesday, hitting $71.18. The stock had a trading volume of 370,962 shares, compared to its average volume of 1,675,936. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm's 50 day moving average price is $67.67 and its 200-day moving average price is $71.69. The company has a market capitalization of $8.66 billion, a price-to-earnings ratio of 29.29, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the previous year, the company earned $1.10 EPS. The firm's revenue for the quarter was down .1% compared to the same quarter last year. On average, equities research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Insider Activity at Henry Schein

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on HSIC. Wells Fargo & Company cut their price objective on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Barrington Research reduced their price objective on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research report on Tuesday, May 6th. Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Piper Sandler cut their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Finally, UBS Group reduced their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $79.30.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.